Latest Cash Flow News

Oneview Healthcare reported a €4 million cash outflow in Q2 2025, driven by restructuring and lower R&D credits, while securing new US hospital contracts and expanding AI-powered care solutions.

icetana Limited reports its strongest quarterly annual recurring revenue growth in over four years, boosted by a landmark $3.6 million strategic partnership with SoftBank Robotics Group and expanding global deployments.

After divesting its meal kit business, My Foodie Box Limited is actively pursuing acquisition opportunities and a transaction to restore its ASX listing, while maintaining a tight cash position.

Openn Negotiation Ltd has successfully exited voluntary administration following a recapitalisation plan that included issuing new shares and securing a shareholder loan. Despite no substantive business activity in the latest quarter, the company is positioned to continue operations under new management.

Centex Limited and Agriflex Pty Ltd, currently under voluntary administration, have received a Deed of Company Arrangement proposal from PRL Global Limited involving an $8.2 million contribution and a share transfer. Administrators recommend creditors approve the DOCA for better returns and operational continuity.

Wrkr Ltd reports sustained positive operating cash flow and strategic investments positioning it for growth despite an anticipated FY25 EBITDA loss. The company’s landmark deals and platform enhancements signal readiness for upcoming regulatory reforms.

Nuchev Limited reports a record-breaking Q4 FY25 with revenues soaring 167% year-on-year, driven by strong growth across multiple markets and a strategic agency agreement in Australia.

Universal Biosensors reports a $1.59 million improvement in operating cash outflows for Q2 2025, maintaining $2.55 million in cash as it advances commercialization across blood, wine, and water testing markets.

Income Asset Management Group Limited delivered its strongest quarter ever in Q4 FY2025, reporting record revenue and robust growth in funds under advice alongside positive operating cash flow.

Zelira Therapeutics has locked in a $650,000 loan facility secured against its anticipated FY25 R&D tax rebate, aiming to accelerate its HOPE SPV clinical trial and strengthen working capital.

Cue Energy Resources reports steady production with a 29% increase in Australian cash receipts and a major milestone at its Maari field, signaling growth and resilience amid operational challenges.

Epx Limited reports sustained operational improvement with four consecutive quarters of positive cash inflows and a 26% increase in customer receipts for the June 2025 quarter.